-
New monoclonal antibodies designed to stop Epstein Barr virus from attaching to and entering human immune cells
Medical Mythbusting Commentary for April 16, 2026 Source:95% of people carry this virus and scientists may have just found how to stop it Reference:Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.
-
New evidence strongly suggests Epstein-Barr virus (EBV) may help trigger Multiple Sclerosis. Opens the door to further investigation of the mechanism of the disease and if corroborated, lead to vaccines to prevent EBV infection.
Medical Mythbusting Commentary for January 14, 2022 Source:New findings ‘strongly suggest’ Epstein-Barr virus may help trigger multiple sclerosisStrong new evidence suggests a virus triggers multiple sclerosis Reference:Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis